Bioequivalence of Sitagliptin Phosphate/Metformin Hydrochloride Tablets in Healthy Chinese Subjects
Condition:   Healthy Subjects Interventions:   Drug: Sitagliptin Phosphate/metformin Hydrochloride Tablets(JANUMET®,50mg/850mg);   Drug: Sitagliptin Phosphate/metformin Hydrochloride Tablets (50mg/850mg) Sponsor:   The Affiliated Hospital of Qingdao University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 7, 2021 Category: Research Source Type: clinical trials